Scholar Rock Holding (SRRK) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.57% |
| Dec 31, 2025 | 0.56% |
| Sep 30, 2025 | -25.29% |
| Jun 30, 2025 | 19.04% |
| Mar 31, 2025 | 16.67% |
| Dec 31, 2024 | -214.44% |
| Sep 30, 2024 | 27.00% |
| Jun 30, 2024 | 20.11% |
| Mar 31, 2024 | 14.83% |
| Dec 31, 2023 | -28.04% |
| Sep 30, 2023 | 12.10% |
| Jun 30, 2023 | 9.64% |
| Mar 31, 2023 | 12.71% |
| Dec 31, 2022 | 8.23% |
| Sep 30, 2022 | 7.29% |
| Jun 30, 2022 | -76.34% |
| Mar 31, 2022 | 16.91% |
| Dec 31, 2021 | -2.66% |
| Sep 30, 2021 | 12.68% |
| Jun 30, 2021 | 10.32% |
| Mar 31, 2021 | 7.72% |
| Dec 31, 2020 | -193.32% |
| Sep 30, 2020 | 17.65% |
| Jun 30, 2020 | 12.12% |
| Mar 31, 2020 | -2.03% |
| Dec 31, 2019 | 10.58% |
| Sep 30, 2019 | 4.89% |
| Jun 30, 2019 | -15.95% |
| Mar 31, 2019 | 9.10% |
| Dec 31, 2018 | -68.91% |
| Sep 30, 2018 | 9.63% |